Insider · CIK 0002033974

Agarwal Arjun

Reports to the SEC for 1 company · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0002033974

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-12	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−1,458 sh	—	—	56,875
2026-10-12	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−8,541 sh	—	—	76,376
2026-10-12	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+1,458 sh	$34.39	+$50.1K	24,218
2026-10-12	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+8,541 sh	$12.50	+$107K	22,760
2026-10-12	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−200 sh	$82.83	−$16.6K	14,219
2026-10-12	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−1,958 sh	$81.86	−$160K	14,419
2026-10-12	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−2,100 sh	$80.76	−$170K	16,377
2026-10-12	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−5,741 sh	$80.03	−$459K	18,477
2026-09-21	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−533 sh	$95.75	−$51K	14,219
2026-09-15	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−560 sh	$95.71	−$53.6K	14,752
2026-09-11	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+1,459 sh	$34.39	+$50.2K	24,771
2026-09-11	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−1,459 sh	—	—	58,333
2026-09-11	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−8,000 sh	—	—	84,917
2026-09-11	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−200 sh	$94.02	−$18.8K	15,312
2026-09-11	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−2,208 sh	$93.26	−$206K	15,512
2026-09-11	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−4,051 sh	$92.41	−$374K	17,720
2026-09-11	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−3,000 sh	$91.11	−$273K	21,771
2026-09-11	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+8,000 sh	$12.50	+$100K	23,312
2026-08-13	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−8,542 sh	—	—	92,917
2026-08-13	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+8,542 sh	$12.50	+$107K	23,854
2026-08-13	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+1,458 sh	$34.39	+$50.1K	25,312
2026-08-13	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−2,100 sh	$104.67	−$220K	23,212
2026-08-13	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−2,132 sh	$105.57	−$225K	21,080
2026-08-13	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−1,268 sh	$106.63	−$135K	19,812
2026-08-13	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−2,142 sh	$107.71	−$231K	17,670
2026-08-13	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−2,358 sh	$108.46	−$256K	15,312
2026-08-13	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−1,458 sh	—	—	59,792
2026-07-13	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−1,458 sh	—	—	61,250
2026-07-13	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+8,541 sh	$12.50	+$107K	23,853
2026-07-13	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+1,458 sh	$34.39	+$50.1K	25,311
2026-07-13	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−300 sh	$83.07	−$24.9K	25,011
2026-07-13	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−3,743 sh	$84.26	−$315K	21,268
2026-07-13	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−5,656 sh	$84.90	−$480K	15,612
2026-07-13	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−300 sh	$85.63	−$25.7K	15,312
2026-07-13	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−8,541 sh	—	—	101,459
2026-06-22	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−888 sh	$80.01	−$71K	16,011
2026-06-22	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−699 sh	$82.14	−$57.4K	15,312
2026-06-15	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−395 sh	$69.69	−$27.5K	16,899
2026-06-12	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−3,260 sh	$70.34	−$229K	17,294
2026-06-12	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−4,340 sh	$69.85	−$303K	20,554
2026-06-12	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−1,859 sh	$68.34	−$127K	24,894
2026-06-12	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+8,000 sh	$12.50	+$100K	25,294
2026-06-12	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+1,459 sh	$34.39	+$50.2K	26,753
2026-06-12	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−1,459 sh	—	—	62,708
2026-06-12	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−8,000 sh	—	—	110,000
2026-05-18	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+5,833 sh	$34.39	+$201K	26,696
2026-05-18	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−5,833 sh	—	—	64,167
2026-05-18	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−2,000 sh	—	—	118,000
2026-05-18	ORKAOruka Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−700 sh	$61.16	−$42.8K	16,406
2026-05-18	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+2,000 sh	$12.50	+$25K	20,863

Recent filings

Accepted (ET)
Oct 13 16:344
Agarwal Arjun0000907654-26-000106
SEC(opens sec.gov)
Sep 214
Agarwal Arjun0000907654-26-000102
SEC(opens sec.gov)
Sep 154
Agarwal Arjun0000907654-26-000097
SEC(opens sec.gov)
Aug 144
Agarwal Arjun0000907654-26-000075
SEC(opens sec.gov)

Companies

Oruka Therapeutics, Inc.Senior Vice President, FinanceORKA

Address

C/O ORUKA THERAPEUTICS, INC. 855 OAK GROVE AVE., SUITE 100

MENLO PARK, CA, 94025